Madrigal Pharmaceuticals Inc
MDGL
|
|
| |
|
| Trading Volume | 10,075 |
|
|
291.86 - 120.40 |
| Market Cap Full | $ 4.9B |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 3.8% | 15.2% | -16.5% | 15.8% |
| Q2 | - | 10.8% | -4.7% | -27.1% |
| Q3 | - | -12.8% | -36.8% | -9.2% |
| Q4 | - | -3.2% | 61.4% | 346.6% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.8 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| -6.3 | 9 | 12.8 | -20.5 | 11.6 | 19.7 | 0.8 | -12.8 | - | - | - | - |
| 2023 | |||||||||||
| -0.7 | -6 | -10.6 | 28.8 | -10.8 | -17 | -11.1 | -12.3 | -18.9 | -10 | 54.7 | 13.8 |
| 2022 | |||||||||||
| -31.4 | 59.6 | 5.7 | -27.3 | -6.3 | 7.1 | -12 | 14.5 | -9.9 | 9 | -1 | 314 |
| 2021 | |||||||||||
| 11.6 | -1.2 | -3.5 | 16.4 | -17.5 | -13.3 | -10.4 | -5.2 | -3.6 | -2.6 | 6.4 | 2.4 |
| 2020 | |||||||||||
| -8.3 | 3.1 | -21.9 | 25.3 | 38.7 | -2.4 | -9.4 | 4.9 | 10.3 | 6.7 | -7.8 | -6 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -4.2 | -3.4 | -3.3 | -2.3 |
| Q2 | -4.7 | -4.1 | -3.7 | -3.2 |
| Q3 | -5.3 | -4.8 | -3.8 | -3.8 |
| Q4 | 0 | -5 | -3.8 | -3.8 |
| A | -14.26 | -17.2 | -14.6 | -13.1 |